Open access · US-GOV via ClinicalTrials.gov Clinical trial

Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects

Authors not listed

Chandra Duggirala · 2018

Telomere attrition Epigenetic alterations Deregulated nutrient-sensing Cellular senescence Plasma dilution / young plasma Human Randomized controlled trial

＋ Sign in to save

Abstract

This trial is designed to study the effects of monthly transfusions of young healthy male donor plasma on biological age as assessed by DNA methylation levels, and changes in cognitive, renal, and pulmonary function, muscle strength, telomere length, testosterone, estrogen, DHEAS, IGF-1, high resolution C-Reactive protein, and expression of P16INK4a in peripheral blood T lymphocytes and skin biopsies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2018). Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects. <em>Chandra Duggirala</em>. https://clinicaltrials.gov/study/NCT03353597

Vancouver

Anonymous. Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects. Chandra Duggirala. 2018.

BibTeX

@misc{anon2018Revers, title = {Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects}, author = {Anonymous}, journal = {Chandra Duggirala}, year = {2018}, }